Remove 2008 Remove Anaphylaxis Remove Shock
article thumbnail

Review of the ATHOS 3 trial

Northwestern EM Blog

The ATHOS-3 trial in 2017 explored the efficacy of angiotensin II as a vasopressor for severe vasodilatory shock. Severe shock is defined as persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65mmHg and serum lactate <2 despite adequate volume resuscitation.

Shock 52
article thumbnail

REBEL Core Cast 122.0 – Neutropenic Fever

RebelEM

2008 Sep;1138:329-50. Give appropriate fluids, vasopressors, and antibiotics. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department. Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. 2016.11.007. Epub 2016 Dec 29. Freifeld, A.